Title |
The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy
|
---|---|
Published in |
OncoTargets and therapy, October 2015
|
DOI | 10.2147/ott.s92470 |
Pubmed ID | |
Authors |
Chengxin Luan, Zixue Yang, Baoan Chen |
Abstract |
MicroRNAs (miRNAs), a new class of noncoding RNAs, which can hybridize to target messenger RNAs and regulate their expression posttranscriptionally, express differentially in distinct stages of lymphopoiesis and influence the direction of lymphoid precursor maturation. Hence, there is aberrant expression of miRNAs involved in malignant lymphopoiesis, and these aberrations can be used as signatures of acute lymphoblastic leukemia (ALL) with different subtypes. In addition, changes in the expression of several miRNAs may have functional relevance with leukemogenesis or drug resistance. As a result, the reversal of the expression of these miRNAs may alleviate the disease to some extent and improve clinical outcomes. However, among the studies of miRNAs, there are still some problems that need to be solved to understand the function of miRNAs in ALL more thoroughly. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 78 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 12 | 15% |
Student > Ph. D. Student | 11 | 14% |
Student > Bachelor | 8 | 10% |
Researcher | 8 | 10% |
Student > Doctoral Student | 7 | 9% |
Other | 11 | 14% |
Unknown | 21 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 25 | 32% |
Medicine and Dentistry | 9 | 12% |
Agricultural and Biological Sciences | 5 | 6% |
Engineering | 2 | 3% |
Immunology and Microbiology | 2 | 3% |
Other | 7 | 9% |
Unknown | 28 | 36% |